» Articles » PMID: 35596116

Transplantation of Exercise-Induced Extracellular Vesicles As a Promising Therapeutic Approach in Ischemic Stroke

Overview
Publisher Springer
Date 2022 May 20
PMID 35596116
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical evidence affirms physical exercise is effective in preventive and rehabilitation approaches for ischemic stroke. This sustainable efficacy is independent of cardiovascular risk factors and associates substantial reprogramming in circulating extracellular vesicles (EVs). The intricate journey of pluripotent exercise-induced EVs from parental cells to the whole-body and infiltration to cerebrovascular entity offers several mechanisms to reduce stroke incidence and injury or accelerate the subsequent recovery. This review delineates the potential roles of EVs as prospective effectors of exercise. The candidate miRNA and peptide cargo of exercise-induced EVs with both atheroprotective and neuroprotective characteristics are discussed, along with their presumed targets and pathway interactions. The existing literature provides solid ground to hypothesize that the rich vesicles link exercise to stroke prevention and rehabilitation. However, there are several open questions about the exercise stressors which may optimally regulate EVs kinetic and boost brain mitochondrial adaptations. This review represents a novel perspective on achieving brain fitness against stroke through transplantation of multi-potential EVs generated by multi-parental cells, which is exceptionally reachable in an exercising body.

Citing Articles

The Role of Exercise in Regulating the Generation of Extracellular Vesicles in Cardiovascular Diseases.

Shen P, Qiu Y, Sun Y, Jiang Y, Guan X, Cheng M Rev Cardiovasc Med. 2024; 25(11):392.

PMID: 39618876 PMC: 11607504. DOI: 10.31083/j.rcm2511392.


Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions.

Moeinafshar A, Nouri M, Shokrollahi N, Masrour M, Behnam A, Tehrani Fateh S Cancer Cell Int. 2024; 24(1):26.

PMID: 38200584 PMC: 10782702. DOI: 10.1186/s12935-023-03203-2.


Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.

Haupt M, Gerner S, Bahr M, Doeppner T Int J Mol Sci. 2023; 24(5).

PMID: 36901765 PMC: 10002358. DOI: 10.3390/ijms24054334.

References
1.
Virani S, Alonso A, Aparicio H, Benjamin E, Bittencourt M, Callaway C . Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021; 143(8):e254-e743. DOI: 10.1161/CIR.0000000000000950. View

2.
Blauenfeldt R, Hjort N, Gude M, Behrndtz A, Fisher M, Valentin J . A multicentre, randomised, sham-controlled trial on REmote iSchemic conditioning In patients with acute STroke (RESIST) - Rationale and study design. Eur Stroke J. 2020; 5(1):94-101. PMC: 7092733. DOI: 10.1177/2396987319884408. View

3.
Hess D, Badruzzaman Khan M, Kamat P, Vaibhav K, Dhandapani K, Baban B . Conditioning medicine for ischemic and hemorrhagic stroke. Cond Med. 2021; 4(3):124-129. PMC: 8372992. View

4.
Abel F, Murke F, Gaida M, Garnier N, Ochsenfarth C, Theiss C . Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure. PLoS One. 2020; 15(2):e0228948. PMC: 7021285. DOI: 10.1371/journal.pone.0228948. View

5.
Xin H, Li Y, Cui Y, Yang J, Zhang Z, Chopp M . Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013; 33(11):1711-5. PMC: 3824189. DOI: 10.1038/jcbfm.2013.152. View